
View larger version (28K):
[in this window]
[in a new window]
|
FIGURE 5. Scintigraphic imaging of HIF-1 transcriptional activation in NIS group tumors. (A) Scintigraphic imaging of NIS group 1. In NIS group 1, control scintigraphic image (no DFO treatment) was acquired 2 wk after tumor challenge (a = C6, b = C6-CMV-NIS, c = C6-5HRE-NIS, Thy = thyroid, St = stomach, Bl = bladder), and post-DFO image was observed 24 h after administering DFO intraperitoneally. (B) Scintigraphic imaging of NIS group 2. In another hypoxia-induced NIS group 2, tumors were grown for 3 wk (diameter, 2 cm) to allow hypoxia to occur naturally. (C) ROIs on scintigraphic images of NIS group 2. ROIs of thyroid and tumor were drawn on scintigraphic images from B. Tumor or thyroid ratio was calculated for individual mice (n = 4). Statistical significances of ROI results were determined using paired t test. Scintigraphic signal in 3-wk C6-5HRE-NIS tumors was significantly higher than in 2-wk tumors, whereas no significant change was detected in C6 or C6-CMV-NIS tumors. *P < 0.005. (D) Biodistribution of 99mTc-pertechnetate in mice of NIS group 2. After final imaging, tumors were excised, and %ID/g values for 99mTc-pertechnetate in each tumor were calculated (n = 4). Statistical significances of biodistribution results were determined using 2-sided Student t test with equal variances. Radioactivities in C6-5HRE-NIS tumors were significantly greater than those in C6 and C6-CMV-NIS tumors. Bars indicate mean ± SD. *P < 0.005.
|